Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)

China flag China · Delayed Price · Currency is CNY
13.22
+0.47 (3.69%)
Jul 3, 2026, 3:00 PM CST
Market Cap8.25B +21.0%
Revenue (ttm)1.03B -5.7%
Net Income22.53M -91.1%
EPS0.04 -91.0%
Shares Out 623.76M
PE Ratio365.94
Forward PEn/a
Dividend0.14 (1.02%)
Ex-Dividend DateJun 17, 2026
Volume36,340,151
Open12.78
Previous Close12.75
Day's Range12.29 - 13.56
52-Week Range9.61 - 19.11
Beta0.49
Analystsn/a
Price Targetn/a
Earnings DateAug 22, 2026

About SHA:688553

Sichuan Huiyu Pharmaceutical Co., Ltd. research and develops, produces, and sells anti-tumor injection in China and internationally. The company offers injection drug products, such as pemetrexed disodium, methrotraxate, docetaxel, azacitidine, oxaliplatin, cyclophosphamide, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, decitabine, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, amifostine, levofolate calcium, thiotepa, fulvestrant, and milrinone drugs. It also offers moroxydine sodium chloride, ... [Read more]

Sector Healthcare
Founded 2010
Employees 1,366
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688553
Full Company Profile

Financial Performance

Financial Statements